Eritrea: Shirin Alurar Ciwon Sankara na Cervical Cancer Ana Ci Gaba Da Gaban Ƙasa
Ana ci gaba da gudanar da shirin rigakafin cutar kansar mahaifa a fadin kasar daga ranar 21 ga watan Nuwamba.Ma’aikatar lafiya ta bayyana cewa an kammala shirye-shiryen gudanar da shirin na rigakafin cikin nasara, ma’aikatar lafiya ta bayyana cewa, an gudanar da gangamin wayar da kan jama’a a dukkan harsuna tun watan Satumban da ya gabata ta hanyar kafa runduna ta musamman a yankuna 67.Ma’aikatar ta kuma ce ana gudanar da shirin rigakafin a makarantu dubu 1 da 382, da cibiyoyin lafiya sama da 300 da kuma cibiyoyin wucin gadi 250 da na’urorin tafi da gidanka 60 da mata dubu 300 daga shekara 9 zuwa 14 za su yi allurar.Ma'aikatar ta ci gaba da cewa jima'i ba tare da kariya ba yana daya daga cikin abubuwan da ke haifar da cututtuka kuma allurar rigakafi na da kashi 95% na shawo kan yaduwar cutar.Ciwon daji na mahaifa shi ne kisa na hudu a matakin duniya kuma na biyu a matakin Afirka kuma a duniya cikin mutane dubu 560 da ke fama da cutar kansar mahaifa 275 daga cikinsu ke rasa rayukansu.Ma'aikatar ta kuma yi kira ga dukkan cibiyoyin da abin ya shafa da kuma jama'a da su karfafa hadin gwiwa domin samun nasarar aiwatar da shirin. Kamar I Love PDF, a nan akwai Adobe PDF hira, matsawa da haɗin kai. Kuna iya canza kalma zuwa pdf anan. Kuna iya canza Excel zuwa pdf anan. Kuna iya canza ppt zuwa pdf anan. Kuna iya canza jpg zuwa pdf anan. Kuna iya canza pdf zuwa kalma anan. Kuna iya canza pdf zuwa powerpoint (ppt) anan. Kuna iya canza pdf zuwa jpg anan. Kuna iya canza pdf zuwa Excel anan. Kuna iya damfara pdf anan. Kuna iya haɗa pdf anan. Hakanan zaka iya damfara da rage girman fayil ɗin hoto akan layi kyauta anan.Batutuwa masu alaƙa:Maganin farko na rigakafin cutar zazzabin cizon sauro ba ga manya ba – FG Gwamnatin Tarayya ta ce za a yi allurar rigakafin cutar zazzabin cizon sauro na farko da Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar a allurai hudu ga jarirai ‘yan watanni 5.
WHO ta kuma ce allurar rigakafin za ta yi tasiri a kan muggan kwayoyin cuta, musamman ma a nahiyar Afirka kuma ba na manya ba. Ministan Lafiya, Dr Osagie Ehanire, ne ya bayyana hakan a ranar Talata a Abuja, yayin taron ministoci na mako biyu kan sabunta martanin COVID-19 da ci gaba a fannin kiwon lafiyar kasar. Kamfanin Dillancin Labaran Najeriya ya bayar da rahoton cewa, rahoton zazzabin cizon sauro na duniya na shekarar 2021 (WMR 2021), ya nuna cewa Najeriya na bayar da kashi 27 cikin 100 na masu kamuwa da cutar zazzabin cizon sauro a duniya da kuma kashi 32 cikin 100 na mace-macen zazzabin cizon sauro a duniya. Ministan ya ce kasar ta ga jimillar cutar miliyan 57 a kowace shekara da kuma mutuwar kusan 100,000 a shekara.Laberiya ta sami ci gaba a cikin rigakafin COVID-19, bayan da ta yiwa kashi 70% na yawan mutanen da suka cancanci allurar riga-kafi tun daga Maris 2021, lokacin da aka fara shirin rigakafin. Haɗin kai mai ƙarfi tsakanin gwamnati da abokan haɗin gwiwarta, ingantaccen kwamitin gudanarwa na COVID-19, da yaƙin neman zaɓe da yawa duk sun ba da gudummawa ga nasarar ƙasar.
Yanzu haka kasar na tabbatar da cewa an kare mafi yawan mutanenta daga munanan cututtuka, asibitoci da kuma mace-mace daga cutar. Ana ci gaba da kokarin cimma manyan matakan rigakafin alluran rigakafi a tsakanin kungiyoyin da ke da fifiko, da suka hada da ma'aikatan kiwon lafiya, manya da suka haura shekaru 60 da haihuwa, masu fama da cututtuka, da 'yan gudun hijira da kuma 'yan gudun hijira. Ana ci gaba da shirye-shirye don ranar rigakafin COVID-19 a Makarantar High Extension ta Bahn a Bahn, Ƙasar Nimba, arewa maso gabashin Laberiya. Makarantar dai tana wajen sansanin 'yan gudun hijira na Bahn, wanda ke da 'yan gudun hijira kusan 10,000 da suka tsere daga rikicin da ya biyo bayan zaben Cote d'Ivoire fiye da shekaru goma da suka gabata. Makarantar, wacce ke ba da ilimi ga yaran Laberiya da 'yan gudun hijira, ɗaya ne daga cikin rukunin yanar gizon da ke ba da rigakafin al'umma kan COVID-19. “Manufarmu ita ce mu tabbatar da an yiwa mutane da yawa allurar rigakafi. Ta haka za mu kasance cikin aminci, ”in ji Oretha Vanwen, wata ma’aikaciyar lafiya ta al’umma wacce ke ba da rigakafin COVID-19 ga ‘yan gudun hijirar da kuma jama’ar da ke karbar bakuncin. A cikin layin yin rajista don rigakafin COVID-19 shine Bernard Manhan, ɗan shekara 57, mahaifin 'ya'ya takwas wanda ke zaune a sansanin 'yan gudun hijira na Bahn. Tare da matarsa da 'ya'yansa, ya gudu zuwa Laberiya a cikin 2011. Manhan dan jam'iyyar adawa ne a lokacin zaben 'yan majalisar dokokin kasar Cote d'Ivoire a shekara ta 2011. A tashin hankalin da ya biyo bayan zaben, ya rasa yawancin 'yan uwansa. "'Yan tawayen sun bi ni," in ji shi, yana ba da labarin wata mayaudariyar abin da ya faru na gudu zuwa makwabciyarta Laberiya don tsira. “Har yanzu ina tsoron rayuwata. Wannan shi ne dalilin da ya sa ban yi wani yunƙuri na komawa gida ba,” in ji ta da azama. Zuwan Laberiya babban taimako ne ga Manhan da danginta saboda yanzu suna da damar samun muhimman ayyukan kiwon lafiya, gami da allurar rigakafin COVID-19. Abokan hulɗa irin su Babban Darakta Janar na Kare Farar Hula na Tarayyar Turai da Ayyukan Ba da Agajin Gaggawa (ECHO) suna tallafawa ƙoƙarin Hukumar Lafiya ta Duniya (WHO) don tabbatar da cewa ba a bar mutane irin su Manhan a baya ba a ƙoƙarin ƙasar na kare al'ummomin da ke da rauni daga cikin mawuyacin hali. mummunan tasirin kwayar cutar. "Lokacin da na ji labarin rigakafin COVID-19 ban gamsu da cewa ba shi da lafiya kuma ina jin tsoron zama mai rauni, tunda jita-jita ce ke yawo," in ji shi. “Duk da haka, matata ta ci gaba da ɗaukar mata tsinke, kuma babu abin da ya canza. Tana cikin koshin lafiya. Don haka na yanke shawarar yin alluran rigakafi kuma na yi farin ciki da na yi, ”in ji ta, tare da nuna alfaharin nuna shaidar ta COVID-19. Wata 'yar gudun hijira daga Cote d'Ivoire, Dekonti Elisabeth Gbe, ita ma ba ta da tabbas game da amincin rigakafin COVID-19, wanda hakan ya sa ta yi shakkar yin allura. "Da yake ina mahaifiya mara aure, na ji tsoron mafi muni," in ji ta. “Idan na yi rashin lafiya kuma na mutu daga allurar fa? Me zai faru da 'ya'yana? Ta gaya mata, yayin da ta tuna tunaninta na farko game da maganin. Amma bayan da ya ga cewa an yi wa mutane da yawa a sansanin ‘yan gudun hijira na Bahn allurar rigakafi kuma ba su fuskanci wani mummunan sakamako ba, Gbe ya yanke shawarar ci gaba da yin rigakafin. “Mutanen da aka yi wa allurar suna cikin koshin lafiya, ciki har da mata masu juna biyu. Na gamsu sosai cewa alluran rigakafi ba su da lafiya, ”in ji ta cikin karfin gwiwa. Nimba na ɗaya daga cikin gundumomi shida WHO ke tallafawa don taimakawa hanzarta rigakafin COVID-19. “WHO ta amince da hadin gwiwa mai karfi da hadin gwiwa tare da ECHO wanda ya taimaka wajen kara yawan allurar. Muhimmin rawar da kananan hukumomin Nimba suka taka, da kuma mallakar tsarin da al'ummomin suka yi, ya taka muhimmiyar rawa wajen tabbatar da cewa an kare al'ummomin Nimba daga COVID-19," in ji Dokta Peter Clement, Wakilin WHO a Laberiya. "Idan muka ci gaba ta wannan hanyar, Laberiya za ta kara kaimi a kokarinta na kare mutanen da ke kiranta gida."Afirka ta sami ci gaba wajen yin allurar rigakafin COVID-19. Nahiyar ta sami kusan allurar COVID-19 miliyan 824 zuwa yau. Cibiyar COVAX, dandamalin da aka kafa don sauƙaƙe daidaito a cikin rarraba alluran rigakafi na duniya, ya ba da fiye da kashi 60% na waɗannan allurai, yayin da kusan kashi 33% ƙasashe suka samu ta hanyar yarjejeniyoyin haɗin gwiwa da gudummawa. Kungiyar Alurar riga kafi ta Afirka ta yi watsi da kusan kashi 7% yayin da sauran suka fito daga wasu kafofin.
Yayin da har yanzu yawan allurar riga-kafi ya yi ƙasa da ƙasa, inda kashi 19% na al'ummar Afirka kaɗai ke da cikakkiyar allurar riga-kafi, wasu ƙasashe sun hanzarta fitar da allurar rigakafin a cikin watanni shida na farkon shekarar 2022. a karshen shekarar 2021, tara ya zarce kashi 15 cikin dari a karshen watan Mayun 2022. Wadannan kasashe sun aiwatar da kamfen din allurar rigakafin cutar a fadin kasar baki daya tare da hada rigakafin COVID-19 a cikin yakin rigakafin yau da kullun. Shida daga cikin wadannan kasashe sune wadanda suka sami gagarumin tallafi daga kungiyoyin tallafi na kasashe da dama da suka hada da WHO, UNICEF, Gavi, Kungiyar Alurar riga kafi da sauran abokan hulda. Waɗannan ƙungiyoyin za su ci gaba da tallafawa ƙasashen da ke da ƙasa da kashi 10% na al'ummarsu gabaɗaya a cikin watanni shida na ƙarshe na 2022 don buɗe kudade da haɓaka dabarun isar da rigakafin da aiwatar da yaƙin neman zaɓe a ƙarshen shekara. Ya zuwa yau, aƙalla ƙasashe 32 sun shirya gagarumin gangamin rigakafin har zuwa ƙarshen shekara. A lokacin yakin neman zabe na jama'a, WHO ta ba da shawarar cewa kasashe su kafa ingantattun dabarun ba da sabis don rigakafin da aka yi niyya na ƙungiyoyi masu fifiko: ma'aikatan kiwon lafiya, tsofaffi, da masu kamuwa da cuta.Sashen-Faransa, haɗin gwiwar magunguna na Burtaniya - Sanofi-GSK -
sun sanar a ranar Juma'a cewa an yi nasarar gwada rigakafin su na COVID-19 akan bambancin Omicron na Coronavirus.
AstraZeneca's (www.AstraZeneca.com) An amince da rigakafin COVID-19 a cikin Tarayyar Turai (EU) ta Hukumar Kula da Magunguna ta Turai (EMA) a matsayin kashi na uku na ƙarfafawa a cikin manya.
Kwararrun kiwon lafiya yanzu za su iya amfani da rigakafin AstraZeneca COVID-19 a matsayin kashi na uku na ƙarfafawa a cikin marasa lafiya waɗanda a baya suka karɓi jadawalin rigakafin farko na AstraZeneca COVID-19 ko kuma rigakafin COVID-19 mRNA da EU ta amince da shi. Izinin ya dogara ne akan wani bita da Kwamitin Kula da Magunguna don Amfani da Dan Adam (CHMP) ya yi na ɗimbin shaidun da ke nuna ƙarin amsawar rigakafi bayan kashi na uku na haɓakawa tare da rigakafin AstraZeneca COVID-19 biyo bayan shirin rigakafin farko na AstraZeneca COVID -19 rigakafi ko COVID-19 mRNA rigakafin. [1-5] Ko da yake sama da kashi 65% na al'ummar duniya sun sami aƙalla kashi ɗaya na rigakafin cutar COVID-19 [6]Babban ƙalubale ya rage wajen tabbatar da cewa mutane sun karɓi duka jadawalin rigakafinsu na farko da kashi na uku na haɓakawa, kuma ƙwararrun kiwon lafiya yanzu suna da sassaucin ra'ayi a zaɓin rigakafin. Mene Pangalos, Mataimakin Shugaban Kasa, BioPharmaceuticals R&D, AstraZeneca ya ce: “Izinin tallace-tallace na yau don rigakafin AstraZeneca na COVID-19 a matsayin mai haɓaka kashi na uku muhimmin mataki ne ga burinmu na samar da ci gaba da kariya daga COVID-19 ga duk mutane. yawan jama'a. Tabbatar da tsayin daka na kariyar rigakafi yana da mahimmanci don gudanar da dogon lokaci na COVID-19 a duniya, kuma masu haɓakawa za su iya magance faɗuwar kariyar na tsawon lokaci wanda aka gani tare da duk jadawalin rigakafin farko zuwa yau. kwanan wata". Akwai adadi mai yawa na shaida da ke tallafawa rigakafin AstraZeneca COVID-19 a matsayin mai haɓaka kashi na uku bayan duk jadawalin rigakafin farko da aka gwada har zuwa yau, gami da rigakafin AstraZeneca COVID-19, rigakafin mRNA, da CoronaVac [1,7-12]. An riga an ba da lasisin rigakafin AstraZeneca COVID-19 a matsayin mai haɓaka ɗabi'a (marasa lafiya waɗanda a baya sun karɓi jadawalin rigakafin farko na rigakafin AstraZeneca COVID-19) a cikin Burtaniya da ƙasashe da yawa a Asiya da Latin Amurka. Hakanan an ba ta lasisi azaman haɓaka mai haɓakawa (marasa lafiya waɗanda a baya sun karɓi tsarin rigakafin farko na maganin ƙwayar cuta na ƙwayar cuta ban da rigakafin AstraZeneca COVID-19 ko rigakafin da ba a kunna ba ko rigakafin COVID-19 mRNA) a cikin ƙasashe da yawa waɗanda ba EU ba. Tarayyar Turai. . An kiyasta cewa rigakafin AstraZeneca COVID-19 ya taimaka wajen hana cutar miliyan 50 na COVID-19, asibitoci miliyan biyar da ceton rayuka sama da miliyan daya a duk duniya, bisa ga samfurin samfurin da ke tantance COVID-19 a duk duniya. duniya. [13]. AstraZeneca COVID-19 (ChAdOx1-S [Recombinant]da AZD1222) Jami'ar Oxford ce ta kirkiro maganin AstraZeneca COVID-19. Yana amfani da ƙwayar cuta mai rarrashin ƙwayar cuta ta chimpanzee dangane da raunin nau'in kwayar cutar sanyi ta gama-gari (adenovirus) wacce ke haifar da cututtuka a cikin chimpanzees kuma tana ƙunshe da kayan halitta don furotin mai karu na ƙwayar cuta ta SARS-CoV-2. Bayan alurar riga kafi, ana samar da furotin mai karu a saman, wanda ke haɓaka tsarin rigakafi don kai hari kan ƙwayar cuta ta SARS-CoV-2 idan daga baya ta cutar da jiki. Alurar rigakafin AstraZeneca COVID-19 rigakafi ce ta 'viral vector', ma'ana cewa nau'in kwayar cutar da ba za ta iya haifar da cuta ba ana amfani da ita a matsayin wani bangare na rigakafin, barin jiki ya san yadda zai yi yaki da ita idan an kamu da kwayar cutar ta gaske. daga baya. Masana kimiyya sun yi amfani da wannan fasahar rigakafin shekaru 40 da suka gabata don yaƙar sauran cututtuka kamar mura, Ebola, da kuma HIV. [14]. An ba da izinin tallan na sharadi ko amfani da gaggawa a cikin ƙasashe sama da 125. Har ila yau, tana da Lissafin Amfani da Gaggawa na Hukumar Lafiya ta Duniya, wanda ke hanzarta hanyar shiga har zuwa kasashe 144 ta hanyar COVAX Facility. Ƙarƙashin yarjejeniyar lasisi tare da AstraZeneca, Cibiyar Serum ta Indiya ce ta kera kuma ta ba da maganin a ƙarƙashin sunan COVISHIELD. Magana: Maheshi N Ramasamy et al. Immunogenicity da amincin AZD1222 (ChAdOx1 nCoV-19) da AZD2816 azaman masu haɓaka kashi na uku a cikin manya waɗanda a baya aka yi musu alurar riga kafi tare da AZD1222 ko rigakafin mRNA. An gabatar da shi a Ƙungiyar Tarayyar Turai don Clinical Microbiology da Cututtuka (ECCMID) Congress, Lisbon, 2022. Flaxman A, et al. Reactogenicity da immunogenicity bayan ƙarshen kashi na biyu ko kashi na uku na ChAdOx1 nCoV-19 (AZD1222) a cikin Burtaniya: ƙari na gwaje-gwajen sarrafawa guda biyu (COV001 da COV002). lancet Akwai a: https://bit.ly/3lUSEhT. An shiga Mayu 2022. Munro A PS, et al. Tsaro da rigakafi na allurar COVID-19 guda bakwai a matsayin kashi na uku (ƙarfafa) bayan allurai biyu na ChAdOx1 nCov-19 ko BNT162b2 a cikin Burtaniya (COV-BOOST): makafi, cibiyar tsakiya, bazuwar, gwajin lokaci na 2 mai sarrafawa .The lancet. Akwai a: https://bit.ly/3sS43Tq. An isa ga Mayu 2022. Mahalarta sun kasance manya masu shekaru 18 da haihuwa waɗanda za su ci gajiyar rigakafin tare da Evusheld, wanda aka ayyana azaman haɗarin rashin isasshen amsa ga rigakafin aiki (amsar da aka annabta ga alluran rigakafi ko rashin haƙuri ga alurar riga kafi) ko tare da ƙarin haɗari Liu X et al. Alabama. Amintacce da rigakafin rigakafi na heterologous tare da jadawalin haɓakawa na farko na gama gari tare da adenoviral-vectored da mRNA (Com-COV) COVID-19 rigakafin: makafi ɗaya, bazuwar, gwaji mara ƙarancin ƙanƙanta. Akwai a: https://bit.ly/3NvsaPI. An shiga Mayu 2022. Dejnirattisai W et al. SARS-CoV-2 Omicron-B.1.1.529 yana kaiwa ga yaɗuwar tserewa daga kawar da martanin antibody. Akwai a: https://bit.ly/3LA5oVm. An shiga Mayu 2022. Ritchie et al. Alurar riga kafi game da coronavirus (COVID-19): duniyarmu a cikin bayanai. Karanta nan: https://bit.ly/38FL73t. An isa ga Mayu 2022 Flaxman A, et al. Reactogenicity da immunogenicity bayan ƙarshen kashi na biyu ko kashi na uku na ChAdOx1 nCoV-19 (AZD1222) a cikin Burtaniya: ƙari na gwaje-gwajen sarrafawa guda biyu (COV001 da COV002). Akwai latsa nan a: https://bit.ly/39N3Hqe. An shiga Mayu 2022. Munro A PS, et al. Tsaro da rigakafi na allurar COVID-19 guda bakwai a matsayin kashi na uku (ƙarfafa) bayan allurai biyu na ChAdOx1 nCov-19 ko BNT162b2 a cikin Burtaniya (COV-BOOST): makafi, cibiyar tsakiya, bazuwar, gwajin lokaci na 2 mai sarrafawa .The lancet. Akwai a: https://bit.ly/3yWlgii. An shiga Mayu 2022. Jara A et al. Ingantattun allurar rigakafin homologous da heterologous don inganta rigakafin SARS-CoV-2: babban binciken lura. Akwai akan SSRN: https://bit.ly/39NmlP4. An shiga Mayu 2022. Vargas L et al. Nazarin serological na rigakafin CoronaVac da ƙarar haɓakawa a cikin Chile: rigakafi da tsayin daka na ƙwayoyin rigakafin SARS-CoV-2 S. Akwai a nan: https://bit.ly/38aPTpa. An shiga Mayu 2022. Costa Clemens SA, et al. Heterologous vs comologous COVID-19 inganta rigakafin rigakafi a cikin waɗanda suka riga sun karɓi allurai biyu na rigakafin CoronaVac COVID-19 a Brazil (RHH-001): nazarin makafi guda 4 bazuwar. Akwai a: https://bit.ly/3sV3k3U. An isa ga Mayu 2022. Ƙididdiga na bayanai dangane da sakamakon samfurin tare da watsawa da aka ayyana azaman cututtuka 200 a cikin mutane 100,000 kowace rana. Rayuwar AZD1222 da asibiti sun hana bayanai akan fayil. Lambar Bayanai akan Fayil: REF-131228, 10 Nov 2021. AstraZeneca UK Ltd. Zhang et al. Dabarun tushen vector na adenoviral akan cututtuka masu yaduwa da ciwon daji. Akwai a: https://bit.ly/3act3hz. An shiga Mayu 2022
Masu bincike a Japan sun ce bambance-bambancen Omicron na COVID-19 yana iya yaɗuwa sosai har ma a tsakanin mutanen da aka yi wa alurar riga kafi ko waɗanda suka riga sun kamu da wasu nau'ikan ƙwayar cuta.
Kafofin yada labarai na cikin gida sun ba da rahoto a ranar Alhamis cewa, a wani taron kwamitin ba da shawara ga ma’aikatar lafiya, wata kungiya karkashin jagorancin Farfesan Jami’ar Kyoto, Hiroshi Nishiura ta ba da rahoton sakamakon binciken da suka yi kan saurin yaduwar nau’in Omicron a Afirka ta Kudu.
Kungiyar ta yi nazari kan bayanan kwayoyin halittar mutum kusan 200 da aka ruwaito daga Afirka ta Kudu daga watan Satumba zuwa karshen watan Nuwamba, bisa ga bayanan kasa da kasa.
Dangane da sakamakon nasu, yawan haifuwa mai inganci, wanda ke wakiltar matsakaicin adadin mutanen da kowane mai cutar ke kamuwa da shi, ya ninka sau 4.2 fiye da na bambancin Delta a lardin Gauteng na Afirka ta Kudu da ke fama da matsalar Omicron. .
Bugu da ƙari, ƙimar har yanzu yana da fiye da sau biyu ko da bayan daidaita bayanai don asusu don nuna son kai.
Kungiyar ta ce ba a san ainihin yadda Omicron bambance-bambancen da kansa ke yadawa ba ya zuwa yanzu.
Koyaya, ta kara da cewa tasirin rigakafin COVID-19 da aka samu don kariya daga kwayar cutar ya tsaya kusan kashi 20 cikin 100 a Afirka ta Kudu.
Nishiura ya ce bambance-bambancen Omicron na iya haifar da babban haɗari ko da a cikin ƙasashen da ke da yawan allurar rigakafi.
Ya ce zai jira muhimman bayanai da suka hada da tsanani, bambance-bambancen musabbabin da kuma tasirin rigakafin.
Xinhua/NAN
Gwamnatin Tarayya ta shirya yin allurar kashi 70 na al’ummar Najeriya kafin karshen shekarar 2022.
Shugaban Kwamitin Shugaban Kasa kan COVID-19, Boss Mustapha, ya ba da wannan tabbacin a Abuja ranar Litinin.
Mista Mustapha, kuma Sakataren Gwamnatin Tarayya, SGF, ya yi magana a taron COVID-19 na Najeriya 2021.
Ya ce: “Yanzu muna cikin zamanin da ake yin alluran rigakafi da matakan ba da magunguna.
"Muna buƙatar ƙarfafa duk waɗanda suka cancanta su yi allurar rigakafin tare da lura da wanke hannu, sanya abin rufe fuska, kiyaye nesa ta jiki da kuma guje wa wuraren cunkoson jama'a.
“Najeriya ta saka hannun jarin alluran rigakafin da za su iya rufe sama da kashi 70 na al’ummarmu kafin karshen shekarar 2022.
“Wadannan alluran rigakafin suna da lafiya kuma suna da inganci; yana da kyau kuma mafi aminci a yi masa allurar rigakafin wannan cutar, yanzu. "
SGF ta ce taron ya yi alkawarin samun lada.
“A karshe, ana sa ran za mu aiwatar da abubuwa kamar haka: nazari kan martanin da kasar ta bayar na COVID-19 daga Fabrairu 2020 zuwa Nuwamba 2021 don gano nasarori, gibi da darussan da za mu koya; gano albarkatun da samar da dabarun da za su aiwatar da alkawurran kasa da kasa da aka bayyana na kawo karshen COVID-19 nan da 31 ga Disamba, 2022," in ji shi.
A cewarsa, sauran sune ci gaba da tsarin ba da amsa ga COVID-19 da kuma tsaron lafiya a Najeriya da kuma tsara tsarin murmurewa Najeriya daga cutar.
Mista Mustapha ya kara da cewa sauran abubuwan da ake tsammanin su ne bayyana shawarwarin da za a iya aiwatarwa ga shugaban kasa Muhammadu Buhari kan tsarin mulki, albarkatun kasa da manufofin da ake bukata don kawo karshen COVID-19 a Najeriya nan da ranar 31 ga Disamba, 2022.
Ya ce, shawarwarin za su hada da yadda za a sake gina tsarin kiwon lafiya da tattalin arziki don samun ingantacciyar hanyar magance barazanar da ke gaba.
Dangane da martanin da Najeriya ta bayar na COVID-19, SGF ta ce: “Kimiyya, bayanai da gogewa ne suka tafiyar da shi tun daga lokacin har zuwa yau.
“Amsar da aka yi na kasa ya kasance ne ta hanyar tsari mai bangarori daban-daban wanda ya sauƙaƙa yin nazari mai zurfi da zurfi kan batutuwa tare da yanke shawara cikin sauri.
“Tsarin ya sami gagarumin goyon baya daga abokan tarayya daga kamfanoni masu zaman kansu da na duniya.
"Ta hanyar waɗannan abokan hulɗa, Najeriya ta sami damar samar da muhimman ababen more rayuwa a cikin ƙasa baki ɗaya, samar da ƙarancin kayan aikin likita, na'urorin gwaji da kayan kariya," in ji shi.
Taron ya kasance mai taken "Tura ta Tsawon Mile na Ƙarshe don Ƙarshen Cutar da Ƙaddamar da Komawa".
Taron dai taro ne na manyan masu ruwa da tsaki a fannin kiwon lafiya, tattalin arziki, tsaro da kuma tsara manufofi na kasar.
NAN
Ministan Lafiya, Dr. Osagie Ehanire, ya ce wani bangare ko cikakken allurar rigakafin COVID-19 da ake jin tsoro bai isa ba don barin ayyukan da ba na magunguna ba, NPIs, masu gadi, ko garantin kamuwa da cuta.
Mista Ehanire ya bayyana hakan ne a ranar Litinin a Abuja, a wurin taron kasa na kwamitin shugaban kasa, PSC, kan COVID-19.
“Kawo yanzu Najeriya ta gwada jimillar samfurori 3,392,457, daga cikinsu 213,147 aka tabbatar sun kamu da COVID-19, yayin da wadanda suka kamu da cutar sun kai 4,447, kuma wadanda aka sallama zuwa yau sun kai 205,732.
“Akwai bakin ciki 2,968 masu alaka da COVID-19 tare da adadin wadanda suka mutu ya kai kashi 1.39.
"Cutar kamuwa da cuta a yanzu a wasu kasashen Turai, wadanda suka riga sun yi allurar rigakafi sama da kashi 60, tabbaci ne cewa cikakken rigakafin ba dalili ba ne na watsi da tsarinmu, ko garantin kamuwa da cuta," in ji Mista Ehanire.
Ministan ya kuma ce yawan kwanciya a cikin makon da ake bitar ya kai kashi 16.17 cikin 100 a cikin sassan keɓewa 86, kuma ana samun iskar oxygen a ko'ina, galibi a cikin silinda, tare da iskar oxygen a baya.
“Babu karuwa a cikin bukatar. Ana ci gaba da yin bita kan yanayin iskar oxygen a cibiyoyin jiyya 125, don kuma gano shuke-shuken da ba sa aiki don gyarawa, "in ji shi.
Mista Ehanire ya ce yawancin marasa lafiya (kashi 67) da aka shigar da su a wuraren keɓewa suna da cututtukan haɗin gwiwa kamar su ciwon sukari, hauhawar jini, kiba da sauran cututtukan da ba sa yaɗuwa (NCDs), waɗanda sanannun masu tantance tsananin cutar COVID-19.
“An yi irin wannan binciken a wasu kasashen Gabashin Turai inda a halin yanzu guguwar COVID-19 ke ta kama.
"Duk da gajiyar da ke tsakanin 'yan kasa kan bin ka'idojin rigakafin COVID-19, da kyar ban ci karo da duk mutumin da ba shi da abin rufe fuska.
"Abin ban mamaki, za su bar abin rufe fuska a aljihu ko jakar hannu kuma su sanya shi akan buƙata.
“Wasu kuma suna sawa a hantarsu. Mask ba ya taimaka a ko'ina sai dai yana rufe baki da hanci.
"Halayen duniya suna ba da shawarar cewa matakan kiwon lafiyar jama'a kamar abin rufe fuska da nisantar da jama'a har yanzu kariya ce mai fa'ida daga kamuwa da cuta," in ji shi.
Ministan ya ce, allurar rigakafin da Najeriya ke yi wa ‘yan kasar ta amince da su, inda ya bukaci ‘yan kasar da su yi shakkar su a yi musu allurar.
“Ya zama ruwan dare a cikin kasashen waje da yawa a yanzu cewa ana buƙatar shaidar rigakafin COVID-19, don shigar da su gidajen cin abinci, gidajen sinima, wuraren shakatawa na dare, har ma da shiga jirgi a kan jiragen sama na ƙasa da ƙasa.
“Wannan al’amari yana kara ta’azzara a duniya, kuma ko shakka babu zai fara samun gindin zama a Najeriya nan gaba kadan.
"Ba zan yi mamaki ba idan kamfanonin jiragen sama na cikin gida sun fara neman katunan rigakafin, kafin su hau,"
"Ina ba da shawara cewa kada a bar kowa a baya wajen yin rigakafin, don kada su fuskanci wani abin kunya," in ji shi.
NAN
Daga Alex Enebeli
Wasu mazauna jihar Enugu sun nuna mabanbantan ra'ayoyi game da rigakafin COVID-19 da ke gudana a jihar.
Wasu daga cikin su, wadanda suka zanta da Kamfanin Dillancin Labaran Najeriya (NAN) a ranar Litinin a cikin hirarraki daban-daban, sun ce sun fi son samar da abinci, tsaro da sauran abubuwan more rayuwa ga allurar.
Misis Blessing Eze, wata malama, ta ce ba za ta dauki allurar rigakafin a kasa ba cewa ba abin da mutanen Enugu ke bukata a yanzu ba.
A cewar ta, mutanen a Enugu na bukatar abinci, hanya mai kyau da tsaro domin inganta rayuwar su.
“Hanyar da suke bi game da COVID-19 na wani abu, mutum zai yi mamaki ko akwai kwayar cutar kwayar cuta a cikin jihar, amma ni, allurar ba tawa ba ce.
"Ya kamata su bai wa 'yan siyasa da danginsu, me ya sa suke tuna talakawa a yanzu," in ji ta.
Misis Ngozi Okpara ta ce ta fi son allurar ta Typhoid da zazzabin Malaria kyauta a kan rigakafin COVID-19.
“Typhoid da zazzabin cizon sauro sun fi kashe mu fiye da kwayar cutar corona a kasar kuma babu wani allurar rigakafi kyauta a kanta.
"Amma ni, zan nemi daga mijina ko zan karba ko kar in karba," in ji ta.
A cewar Chukwuemeka Chioke, wani dan kasuwa, na ji cewa allurar rigakafin tana haifar da ciwon kai kuma tana raunana jiki don haka ba zan karba ba.
Amma wata ma’aikaciyar jinya, mai suna Philomena, ta ce za ta dauki allurar tunda wasu ma’aikatan kiwon lafiya a jihar sun mutu daga cutar ta COVID-19.
“Zan karba a duk lokacin da aka kira ni in sha jar. Wasu likitoci da jami'an kiwon lafiya tuni suka sha jab din kuma ba abin da ya same su, ”inji ta.
A halin yanzu, Daraktan, Hukumar Wayar da Kan Kasa (NOA) a Jihar Enugu, Mista Isaac Onukwube ya bukaci mazauna jihar da su rungumi allurar rigakafin.
"Wanda yake raye ne zai yi tunanin hanya da abinci, na san cewa su ne mahimmancin rayuwa amma rayuwa ita ce mafi mahimmanci," in ji shi.
Ya bukace su da su yi watsi da jita-jitar mutuwa da ke tattare da allurar rigakafin ta COVID- 19 saboda allurar gaskiya ce kuma mai lafiya.
Kamfanin dillancin labarai na NAN ya ruwaito cewa a ranar Laraba gwamnatin jihar Enugu ta dauki nauyin allurai 65,000 na AstraZeneca COVID-19. (NAN)
Kamar wannan:Ana lodawa ...
Mai alaka
Zuwan rukunin farko na rigakafin COVID-19 zuwa Nijeriya ya kasance abin farin ciki ga mutane da yawa; musamman wadanda suka kalli Shugaba Muhammadu Buhari da Mataimakinsa Yemi Osinbajo a Gidan Talabijin na Kasa suna daukar hotonsu na farko.
Zanga-zangar ta nuna karbar alurar rigakafin ba wai kawai don wayar da kan mutane ba ne amma kuma tana cire shakku da tsoro a zukatan mutanen da har yanzu ba su yarda da wanzuwar kwayar ba.
Wannan ya faru ne saboda akwai wata dabara da ta shafi makirci da ke nuna cewa allurar tana da hadari ga mutane.
Ka'idar ta kuma yi iƙirarin cewa allurar rigakafin ne don ba da ɗan adam don rage yawan mutanen duniya.
Najeriya ta karbi alluran rigakafin COVID-19 miliyan 3.94 a ranar 2 ga Maris, 2021, don bayar da kyauta ga mutanen da ke son shan ta.
Yana daga cikin allurai miliyan 16 da za'a kawo Najeriya cikin yan makonni masu zuwa.
Najeriya ita ce kasa ta uku daga Afirka bayan Ghana da Ivory Coast da suka karbi allurar, wanda hakan ya yiwu wani shiri na COVID-19 na Rigakafin rigakafin duniya.
Bayan isowar allurar saboda haka, gwamnati, masana harkar lafiya da masana zasu tashi tsaye wajen fadakarwa dan fadakar da jama'a bukatar su ta rigakafi.
Akwai buƙatar ilmantar da jama'a cewa maganin rigakafin yana da lafiya, na iya haɓaka rigakafin mutum kuma yana iya karewa daga mummunan sakamako.
Dr Peter Akumba, wani kwararren likita ne, ya fadawa Kamfanin Dillancin Labaran Najeriya (NAN) cewa “mu buƙatar ƙirƙirar wayar da kan jama'a game da ingancin allurar kayar da masu shakka.
"Bai kamata a yi siyasa a ciki ba, ya kamata jihohi su dauki nauyin rarrabawa da adana kasonsu na allurar rigakafin da samar da kayan aiki a ciki."
Akumba ya kara lura da cewa Gwamnatin Tarayya ta samu wannan ‘yancin kuma“ muna bukatar mu yaba wa dukkanin hukumomin kiwon lafiya da kwamitocin COVID-19.
“Gwamnatin Tarayya tun daga farko ta dauki bijimin ta kaho, ganin annobar a matsayin yakin da za a hana. Yaki a kan bil'adama, yakin rayuwa daga ƙauyen duniya tare da annoba a duniya, yana barazanar share mu duka. "
Dr Obinna Aduba, aShahararren Likitan nan kuma kwararre kan shawo kan cututtuka, ya yi tir da halayyar wasu 'yan Najeriya game da allurar rigakafin.
Ya ce “tba lokacinsa ba ne da za a yi siyasa da irin wannan annoba ta duniya da ta hallaka sama da mutane miliyan biyu da sama da 500,000 daga Amurka kadai, kuma ana hasashen fargabar barkewar ta biyu da ta uku. ”
Hukumar Lafiya ta Duniya (WHO) ta ce babban abin da aka sa a gaba shi ne fara allurar rigakafin ga ma’aikatan kiwon lafiya wadanda ke da matukar barazanar kamuwa da cutar, sai kuma manyan da ke biye da su, kafin a yiwa sauran rigakafin
A kan mutanen da ke da rashin lafiyan jiki, musamman ma mutane tare da tarihin rashin lafiyan rashin lafia ga duk wani abu na maganin, an basu shawarar kar su sha.
Mata masu ciki da masu shayarwa suna cikin haɗarin COVID-19 mai tsanani fiye da mata marasa ciki, kuma COVID-19 an haɗu da haɗarin haɗuwa da haihuwa kafin lokacin haihuwa.
Koyaya saboda rashin isassun bayanai, WHO ba ta ba da shawarar yin rigakafin mata masu juna biyu a wannan lokacin ba.
Idan mace mai ciki tana da haɗarin kamuwa da cuta mai girma (misali ma'aikacin lafiya), ana iya yin la'akari da allurar rigakafi don tattaunawa tare da masu ba da lafiya.
Idan mace mai shayarwa tana cikin ƙungiyar (misali ma'aikatan lafiya) waɗanda aka ba da shawarar yin rigakafin, ana iya yin rigakafin. WHO ba ta ba da shawarar dakatar da shan nono ba bayan rigakafin.
Akan yara, WHO ba ta ba da shawarar yin allurar rigakafin ƙasa da shekara 16 ba, koda kuwa sun kasance cikin ƙungiyar haɗari.
Akan mutanen da suka san yanayin kiwon lafiya, WHO ta ce allurar rigakafin an gano tana da lafiya da tasiri a cikin mutane masu yanayi daban-daban waɗanda ke da alaƙa da haɗarin kamuwa da cuta mai tsanani.
Wannan ya hada da hauhawar jini, ciwon sukari, asma, huhu, hanta ko cutar koda, da kuma cututtukan da ke ci gaba da zama tsayayye da sarrafawa.
Koyaya, WHO ta ce, ana buƙatar ci gaba da karatu don tasirin tasirin mutanen da ke fama da rigakafi.
“Shawarwarin rikon kwarya shi ne cewa mutane masu rigakafin rigakafi wadanda suke cikin kungiyar da aka ba da shawarar yin allurar rigakafin za a iya yin rigakafin, duk da cewa a lokacin da zai yiwu, ba kafin karbar bayanai da shawara ba.
“Mutanen da ke dauke da kwayar cutar kanjamau na cikin hatsarin kamuwa da mummunar cutar COVID-19. Akwai takaitaccen bayanan tsaro kan mutanen da ke dauke da kwayar cutar ta HIV wadanda ke fama da cutar daga gwaji, '' in ji rahoton na WHO.
Masana sun kuma ba da shawarar cewa ya kamata a sanar da wadanda suka san masu dauke da kwayar cutar HIV, kuma idan ya yiwu, a ba su shawara dangane da bayanan da ake da su.
Hakanan WHO tana ba da shawarar cewa mutanen da suke da ko suna da COVID-19 tuni sun iya kasancewa miƙa, gami da mutanen da ke da COVID-19 a baya.
Amma saboda karancin wadatar allurar, a cewar kungiyar, mutane na iya son jinkirta yin allurar rigakafin nasu na COVID-19 har na tsawon watanni shida daga lokacin kamuwa da cutar ta SARS-CoV-2.
“Yayinda ake samun karin bayanai a kan tsawon lokacin rigakafi bayan kamuwa da cuta, ana iya daidaita wannan lokacin.
“Ba a bada shawarar yin gwaji kan kamuwa da cutar ba kafin a yanke shawarar allurar rigakafin, in ji hukumar.
Areaaya daga cikin wuraren da WHO ta faɗi shine matsalar matafiya na duniya.
A yanzu haka, WHO ta ce ba ta goyi bayan gabatar da bukatu don shaidar allurar rigakafin COVID-19 ga matafiya na kasashen duniya a matsayin sharadin fita ko shiga wata kasa ko kuma tafiya kasashen duniya.
Jagoran wucin gadi na WHO game da tafiye-tafiye na ƙasashen duniya yayin annobar ya bayyana a kan wannan.
A kan sashi, sakamako mai karewa yana fara haɓaka kwanaki 12 bayan farawar farko, amma cikakken kariya yana buƙatar allurai biyu waɗanda WHO ke ba da shawarar a gudanar da su daga tazarar 21 zuwa 28.
Koyaya, masana sunce ana buƙatar ƙarin bincike don fahimtar yiwuwar kariya ta lokaci mai tsawo bayan kashi ɗaya.
Suna kuma da ra'ayin cewa allurar rigakafin ba za ta ƙare COVID-19 ita kaɗai ba amma za ta inganta ƙwayoyin cuta, kamar yadda mai lafiya kuma ingantattun alluran rigakafi zasu kasance masu canza wasa.
Amma nan gaba, suna ba da shawara cewa dole ne mutane su ci gaba da sanya masks, lura da nisan jiki, guje wa taron jama'a da amfani da wasu matakan kiwon lafiya.
Yin rigakafi ba yana nufin mutane na iya yin taka tsan-tsan da iska da jefa kansu cikin haɗari ba, musamman saboda har yanzu ba a bayyana ba, matakin da allurar ke iya karewa ba kawai daga cuta ba har ma da kamuwa da cuta da watsawa.
WHO ta ce saboda yawan alluran rigakafin COVID-19 da suka yi daidai da fasahohin dandamali daban-daban, kungiyar na duban allurar rigakafin kamar yadda suka bayar da izini daga manyan hukumomin kula da kasa da ke da wadatar wadata don magance bukatun kasashe da dama.
Hukumar ta kuma ce za ta yi bawa kasashe damar nemo kayayyakin da suka dace da yanayin su. (NANFeatures)
Kamar wannan:Ana lodawa ...
Mai alaka